EurekAlert!

C-Path’s translational therapeutics accelerator announces new grant award for drug development project in type 1 diabetes

TUCSON, Ariz., June 18, 2025 — Critical Path Institute’s® (C-Path) Translational Therapeutics Accelerator (TRxA) proudly announced today a $250,000 grant award aimed at developing a novel treatment ...
EurekAlert!

C-Path’s TRxA announces $1 million award for drug development project in type 1 diabetes

TUCSON, Ariz., November 19, 2024 — Critical Path Institute® (C-Path) today announced that its Translational Therapeutics Accelerator (TRxA) program, in partnership with The Leona M. and Harry B.
News Medical

C-Path’s TRxA awards $250,000 grant to develop novel treatment for type 1 diabetes

Critical Path Institute's ® (C-Path) Translational Therapeutics Accelerator (TRxA) proudly announced today a $250,000 grant award aimed at developing a novel treatment for type 1 diabetes (T1D). Kyle ...
Morningstar

C-Path's New Paper in Nature Reviews Drug Discovery Highlights How to Maximize the Regulatory Impact of Consortium-Based Projects

BRUSSELS and AMSTERDAM, June 16, 2025 /PRNewswire/ -- The Innovative Health Initiative (IHI) and Critical Path Institute® (C-Path) today announced the publication of a peer-reviewed paper in Nature ...
News Medical

C-Path supports innovative ALS, neurodegenerative disease research with new grant

Critical Path Institute's (C-Path) Translational Therapeutics Accelerator (TRxA) announced today a new research grant awarded to Daniela C. Zarnescu, Ph.D., Professor of Cellular and Molecular ...
KXAN

Critical Path Institute Celebrates 20 Years of Advancing Drug Development through Innovation and Collaboration

TUCSON, Ariz., May 8, 2025 /PRNewswire/ -- The year 2025 marks a historic milestone for Critical Path Institute ® (C-Path), as the organization celebrates 20 years of transforming the landscape of ...
MarketWatch

C-Path's Translational Therapeutics Accelerator Marks Record Year with Seven BRIDGe Awards Advancing Potential Therapies Across Cancer, Infectious Disease, Neurology and Immunology

The MarketWatch News Department was not involved in the creation of this content. Program launched in 2022 has grown into a global pipeline partner for academic teams, awarding approximately $2.48 ...
KVOA 4

Critical Path Institute plays a major role in advancing drug development globally

TUCSON, Ariz. (KVOA) — It's been a Tucson based non-profit for two decades. Critical path institute also known as c-path plays a major role in advancing drug development all over the world. Critical ...